Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,209,479 papers from all fields of science
Search
Sign In
Create Free Account
A 78773
Known as:
A-78773
, Urea, N-(3-(5-(4-fluorophenoxy)-2-furanyl)-1-methyl-2-propynyl)-N-hydroxy-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
A 79175
analogs & derivatives
Broader (1)
hydroxyurea
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
1997
Review
1997
Biosynthesis inhibitors for leukotrienes in bronchial asthma.
J. Negro
,
J. Miralles
,
J. Ortiz
,
E. Funes
,
A. García
Allergologia et Immunopathologia
1997
Corpus ID: 7685173
This article reviews the literature on the effects of leukotrienes in asthma. In particular, the ability of recently developed…
Expand
1994
1994
Stereoselective Metabolism of the 5‐Lipoxygenase Inhibitor A‐78773
G. Carter
,
R. Bell
,
+7 authors
D. W. Brooks
Annals of the New York Academy of Sciences
1994
Corpus ID: 21590806
Based on the knowledge that glucuronidation was a major route of metabolism of the N-hydroxyurea class of 5-lipoxygenase…
Expand
1994
1994
Second generation leukotriene biosynthesis inhibitors
A. Basha
,
D. W. Brooks
,
A. Stewart
,
R. Bell
,
G. Carter
1994
Corpus ID: 27130786
Abstract
1993
1993
Preclinical and Clinical Activity of Zileuton and A‐78773
R. Bell
,
C. Lanni
,
+5 authors
G. Carter
Annals of the New York Academy of Sciences
1993
Corpus ID: 11272467
The importance of leukotrienes as mediators of inflammation and bronchoconstriction was examined with two recently described 5…
Expand
1993
1993
A-78773: a selective, potent 5-lipoxygenase inhibitor.
R. Bell
,
D. W. Brooks
,
+5 authors
G. Carter
Journal of lipid mediators
1993
Corpus ID: 26127168
The potency and selectivity of A-78773, a newly discovered 5-lipoxygenase inhibitor, were examined. The compound was…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required